Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease
Clinical trial NCT06099652 · COMPLETED
Trial details
- NCT number
- NCT06099652
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-08
- Primary completion
- 2025-04-15
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.